Clinical Trials Logo
  1. Home
  2. Primary Sjögren Syndrome
  3. NCT03614299

Eye Dryness Evaluation in Primary Sjögren's Syndrome — PEPSS  

Primary Sjögren Syndrome Clinical Trial

Official title:
Pateint-reported Outcomes and Objective Eye Dryness Evaluation in Primary Sjögren's Syndrome.

Clinical Trial Summary

The objective of this observational study is to develop new tools to assess primary Sjögren's syndrome (pSS) symptoms and to measure the severity of eye involvement in these patients.

Clinical Trial Description

All clinical trials evaluating the efficacy of immunomodulatory drugs in pSS are negative. This could be due to a lack of sensitivity of the outcome measures used so far to define the response. In this study, investigator will evaluate the feasability, tolerability, and performance of new tools to assess disease evolution:

- investigator will develop a webapp to measure the intensity of the symptoms at home on a daily basis (ecological assessment)

- investigator will evaluate new ophthalmologic procedures, already used in other conditions but never in pSS, which assess the severity of eye involvement in the disease

- investigator will develop an automated method to score the severity of ocular surface lesions in the disease.

Patients with a diagnosis of pSS will be included in the study, will undergo detailed ophtalmologic examination, and will then use a webapp, installed on their smartphone, to score their symptoms everyday during 3 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03614299
Study type Observational
Source University Hospital, Brest
Contact
Status Not yet recruiting
Phase
Start date October 1, 2019
Completion date December 1, 2020
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03140111 - LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients N/A
Not yet recruiting NCT06049368 - 68Ga-P16-093 PET/CT Imaging in the Salivary Gland Phase 1/Phase 2
Not yet recruiting NCT03126383 - Inflammatory Myopathies in Primary Sjögren's Syndrome N/A
Recruiting NCT04830644 - A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome. Phase 2
Not yet recruiting NCT03765593 - Biomarkers in Primary Sjögren's Syndrome
Completed NCT01081184 - Neurotrophins Implications in Primary Sjögren Syndrome N/A
Completed NCT05670535 - Sjögren and Gynecologic Considerations
Completed NCT03226444 - Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome Phase 1/Phase 2
Completed NCT04816370 - Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions N/A
Completed NCT05380804 - Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome
Terminated NCT04700280 - A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS) Phase 2
Completed NCT03130062 - Resistance Exercise in Woman With Primary Sjörgen Syndrome. N/A
Completed NCT04093531 - Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome Phase 1
Recruiting NCT03509064 - Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
Completed NCT04224454 - Vaccine Coverage and Primary Sjögren'Syndrome
Completed NCT04960605 - Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome N/A
Recruiting NCT06361745 - Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases N/A